GlassScriptPhysician profile
Raymond L Fuller, JR.
NPI 1639374408
$1,558.86
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $690 · 2021: $17.63 · 2022: $13.48.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $269.21 | 2019 | |
| Allergan, INC. | $196.66 | 2019-2020 | |
| Glaxosmithkline, LLC. | $133.73 | 2019-2020 | |
| Amarin Pharma, INC. | $114.20 | 2020 | |
| Merck Sharp & Dohme LLC | $109.69 | 2019-2020 | |
| Pfizer INC. | $102.88 | 2019-2020 | |
| Amgen INC. | $88.88 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $79.60 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.25 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $63.32 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $48.81 | 2020-2021 | |
| Abbvie INC. | $48.80 | 2019-2020 | |
| Novo Nordisk INC | $35.33 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.33 | 2019 | |
| Lilly USA, LLC | $26.08 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $17.20 | 2019 | |
| Medtronic Vascular, INC. | $16.80 | 2019 | |
| Phadia US INC. | $15.97 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.83 | 2020 | |
| Daiichi Sankyo INC. | $13.73 | 2019 | |
| Esperion Therapeutics, INC. | $13.48 | 2022 | |
| Valeritas, INC. | $12.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.12 | 2020 | |
| Astellas Pharma US INC | $11.32 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.